Pharmacy Daily | MA hails “policy certainty”

AUSTRALIAN pharmaceutical manufacturer CSL Limited has announced a major new investment in Australia’s biopharmaceuticals sector, with the $235 million development of a large-scale biotech facility in Victoria. Medicines Australia says the deal shows the importance of government policy certainty, with the investment a clear demonstration of the economic benefit of having an innovative biopharmaceuticals industry here. Acting MA ceo Donna Edman said the project would “stimulate the economy, provide hundreds of high-value jobs to Australian residents and raise the prospect of developing new therapies for Australian patients.” She said the Memorandum of Understanding signed by MA and the government in the lead-up to the May Federal Budget (PD 06 May) had provided the industry with “the stability and policy certainty upon which growth depends. “Australia attracts $1 billion a year in R&D investment and the new venture announced by CSL will help keep Australia at the forefront of the global clinical research sector,” Edman added.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jul 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jul 10